For the coming years, I believe Inderes predicted that capitalizations will exceed depreciation by about 1 million… both sums are certainly large. It’s a good sign that the CFO more than doubled his shareholding last month, and it didn’t happen by selling Talenom. So, could one think that both will be good investments going forward, but Easor might be slightly better? 
I just had to return as a Talenom shareholder now that the share price dropped below 1.3.